KENTWOOD, Mich. and LEWISVILLE, Texas, July 10, 2018 /PRNewswire-PRWeb/ -- BayMark Health
"Across the country, people are suffering from the devastating disease of addiction. The growing opioid crisis has resulted in a two-fold increase in overdose deaths in Michigan since 2012," said David K. White, Ph.D., CEO of BayMark Health Services. "Our focus at BayMark is offering access to proven treatment modalities to as many patients in need as possible. We open programs in areas where treatment options for opioid addiction are limited and there is an identified need, and we found the Greater Grand Rapids area met these criteria."
MedMark programs are known across the country as providers of quality, evidence-based methadone and buprenorphine treatment centers. MedMark programs also provide addiction education, relapse prevention, lab testing, coordinated care for pregnancy and linkages to community resources to assist patients on their path to recovery. Our mission is to provide comprehensive medication-assisted treatment for opioid use disorder and other health care services to foster wellness, longevity and socially responsible behavior for the patients we serve.
Chief Operating Officer Frank Baumann noted, "We are pleased to bring our treatment model to Michigan for the first time. MedMark's medically-supervised treatment programs have provided the opportunity for meaningful recovery to thousands of Americans. Our physicians, nurses, counselors and support staff offer compassionate, respectful treatment of those struggling with opioid use disorder. We believe we can deliver a valuable service to those individuals and their families in the greater Grand Rapids area."
For more information on MedMark visit https://medmark.com/
About BayMark Health Services:
BayMark Health Services provides medication-assisted treatment to more than 46,000 patients in recovery from opioid use disorder. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of prescription pain medication or other opiates. The BayMark continuum of patient-focused services includes highly structured opioid treatment programs utilizing methadone or buprenorphine and office-based buprenorphine programs, both of which incorporate counseling as part of an individualized treatment plan; as well as, ambulatory withdrawal management services with naltrexone therapy, residential treatment and recovery support services.
SOURCE BayMark Health Services
Subscribe to our Free Newsletters!